Search

Anne Marie Falk

Examiner (ID: 7004)

Most Active Art Unit
1632
Art Unit(s)
1632
Total Applications
685
Issued Applications
242
Pending Applications
153
Abandoned Applications
292

Applications

Application numberTitle of the applicationFiling DateStatus
09/494088 Production and use of Dopaminergic cells to treat Dopaminergic deficiencies Jan 27, 2000 Abandoned
Array ( [id] => 4311635 [patent_doc_number] => 06242254 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Recombinant cells regulated by tetracycline' [patent_app_type] => 1 [patent_app_number] => 9/492905 [patent_app_country] => US [patent_app_date] => 2000-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 14 [patent_no_of_words] => 5666 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242254.pdf [firstpage_image] =>[orig_patent_app_number] => 492905 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/492905
Recombinant cells regulated by tetracycline Jan 26, 2000 Issued
Array ( [id] => 754543 [patent_doc_number] => 07018979 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-03-28 [patent_title] => 'Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor' [patent_app_type] => utility [patent_app_number] => 09/491500 [patent_app_country] => US [patent_app_date] => 2000-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 6914 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/018/07018979.pdf [firstpage_image] =>[orig_patent_app_number] => 09491500 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/491500
Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor Jan 25, 2000 Issued
Array ( [id] => 4275854 [patent_doc_number] => 06323391 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Methods and transgenic mouse model for identifying and modulating factors leading to motor neuron degeneration' [patent_app_type] => 1 [patent_app_number] => 9/489979 [patent_app_country] => US [patent_app_date] => 2000-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10084 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/323/06323391.pdf [firstpage_image] =>[orig_patent_app_number] => 489979 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/489979
Methods and transgenic mouse model for identifying and modulating factors leading to motor neuron degeneration Jan 20, 2000 Issued
09/478099 TARGETED TRANSSCLERAL CONTROLLED RELEASE DRUG DELIVERY TO THE RETINA AND CHOROID Jan 4, 2000 Abandoned
09/472188 DNA MOLECULE ENCODING A MUTANT PREPRO-NEUROPEPTIDE Y, A MUTANT SIGNAL PEPTIDE, AND USES THEREOF Dec 26, 1999 Abandoned
Array ( [id] => 1407526 [patent_doc_number] => 06528271 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-04 [patent_title] => 'Inhibition of arrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia' [patent_app_type] => B1 [patent_app_number] => 09/469554 [patent_app_country] => US [patent_app_date] => 1999-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 8 [patent_no_of_words] => 6809 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528271.pdf [firstpage_image] =>[orig_patent_app_number] => 09469554 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/469554
Inhibition of arrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia Dec 21, 1999 Issued
Array ( [id] => 6563621 [patent_doc_number] => 20020138855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'NON-INVASIVE EVALUATION OF PHYSIOLOGICAL RESPONSE IN A MAMMAL' [patent_app_type] => new [patent_app_number] => 09/464795 [patent_app_country] => US [patent_app_date] => 1999-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 29023 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20020138855.pdf [firstpage_image] =>[orig_patent_app_number] => 09464795 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/464795
Non-invasive evaluation of physiological response in a transgenic mouse Dec 15, 1999 Issued
Array ( [id] => 948939 [patent_doc_number] => 06962975 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-11-08 [patent_title] => 'Prion protein standard and method of making the same' [patent_app_type] => utility [patent_app_number] => 09/856230 [patent_app_country] => US [patent_app_date] => 1999-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14373 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/962/06962975.pdf [firstpage_image] =>[orig_patent_app_number] => 09856230 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/856230
Prion protein standard and method of making the same Nov 16, 1999 Issued
Array ( [id] => 6650708 [patent_doc_number] => 20030008342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'SURFACE RECEPTOR ANTIGEN VACCINES' [patent_app_type] => new [patent_app_number] => 09/441411 [patent_app_country] => US [patent_app_date] => 1999-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20592 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008342.pdf [firstpage_image] =>[orig_patent_app_number] => 09441411 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/441411
Surface receptor antigen vaccines Nov 15, 1999 Issued
Array ( [id] => 1059439 [patent_doc_number] => 06852529 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-08 [patent_title] => 'Gloucose-regulated mRNA instability element' [patent_app_type] => utility [patent_app_number] => 09/435471 [patent_app_country] => US [patent_app_date] => 1999-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 49 [patent_no_of_words] => 24060 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/852/06852529.pdf [firstpage_image] =>[orig_patent_app_number] => 09435471 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/435471
Gloucose-regulated mRNA instability element Nov 7, 1999 Issued
Array ( [id] => 1417372 [patent_doc_number] => 06525242 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Propagation of human hepatocytes in non-human mammals' [patent_app_type] => B1 [patent_app_number] => 09/431901 [patent_app_country] => US [patent_app_date] => 1999-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 37 [patent_no_of_words] => 16413 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/525/06525242.pdf [firstpage_image] =>[orig_patent_app_number] => 09431901 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/431901
Propagation of human hepatocytes in non-human mammals Nov 1, 1999 Issued
Array ( [id] => 1261050 [patent_doc_number] => 06664039 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-16 [patent_title] => 'Methods and compositions for modulating neurodegeneration' [patent_app_type] => B1 [patent_app_number] => 09/418963 [patent_app_country] => US [patent_app_date] => 1999-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 25128 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664039.pdf [firstpage_image] =>[orig_patent_app_number] => 09418963 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/418963
Methods and compositions for modulating neurodegeneration Oct 13, 1999 Issued
Array ( [id] => 773297 [patent_doc_number] => 07001770 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-21 [patent_title] => 'Calpain inhibitors and their applications' [patent_app_type] => utility [patent_app_number] => 09/416735 [patent_app_country] => US [patent_app_date] => 1999-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17971 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/001/07001770.pdf [firstpage_image] =>[orig_patent_app_number] => 09416735 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/416735
Calpain inhibitors and their applications Oct 12, 1999 Issued
09/402911 NOVEL PRIA Oct 11, 1999 Abandoned
09/413785 METHODS OF SCREENING FOR APOPTOSIS-CONTROLLING AGENTS FOR BONE ANABOLIC THERAPIES AND USES THEREOF Oct 6, 1999 Abandoned
09/319236 THERAPEUTIC COMPOSITION COMPRISING THE KAL PROTEIN AND USE OF THE KAL PROTEIN FOR THE TREATMENT OF RETINAL, RENAL, NEURONAL AND NEURAL INJURY Sep 1, 1999 Abandoned
Array ( [id] => 948653 [patent_doc_number] => 06962688 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-11-08 [patent_title] => 'Methods for modulation of cholesterol transport' [patent_app_type] => utility [patent_app_number] => 09/385799 [patent_app_country] => US [patent_app_date] => 1999-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 10477 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 194 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/962/06962688.pdf [firstpage_image] =>[orig_patent_app_number] => 09385799 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/385799
Methods for modulation of cholesterol transport Aug 29, 1999 Issued
Array ( [id] => 4322721 [patent_doc_number] => 06331525 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Targeted delivery of genes encoding interferon' [patent_app_type] => 1 [patent_app_number] => 9/379434 [patent_app_country] => US [patent_app_date] => 1999-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 11029 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331525.pdf [firstpage_image] =>[orig_patent_app_number] => 379434 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/379434
Targeted delivery of genes encoding interferon Aug 22, 1999 Issued
09/374742 METHODS AND COMPOSITIONS FOR BISUBSTRATE INHIBITORS OF ACETYLTRANSFERASES Aug 12, 1999 Abandoned
Menu